Use of albumin in three French university hospitals: is prescription monitoring still useful in 2004?

Abstract

Most of albumin consumption in our study is concentrated on recognized indications or indications without alternative to albumin. The different levels of analysis (number of patient treated, number of prescription and quantities used) must be taken into account when analyzing medications such as albumin. Only a marginal proportion of consumption is expected to be saved with close monitoring of indications.

Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals

“…It is important to interpret these results in the light of the design of the study that was conducted in university hospitals. Indeed, university hospitals present a concentration of rare diseases and patients refractory to conventional treatment [27]. They developed a specific activity and act as a reference centre on a regional area, which may explain the important proportion of unlabelled indications in our study and the important number of indications (around 68).…”